adminRockwell Medical, Inc. (NASDAQ:RMTI) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET
Company Participants
Heather Hunter – Senior Vice President, Chief Corporate Affairs Officer
Mark Strobeck – President & Chief Executive Officer
Tim Chole – Chief Commercial Officer
Jesse Neri – Chief Financial Officer
Conference Call Participants
Brandon Folkes – Rodman & Renshaw
Ram Selvaraju – H.C. Wainwright
Anthony Vendetti – Maxim Group
Operator
Good morning, and welcome to Rockwell Medical’s Fourth Quarter and Full Year 2024 Results Conference Call and Webcast. Please note, this event is being recorded.
At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate Affairs Officer at Rockwell Medical. Heather, please go ahead.
Heather Hunter
Good morning, and thank you for joining us for this update on Rockwell Medical.
Joining me on today’s conference call are Dr. Mark Strobeck, Rockwell Medical’s President and Chief Executive Officer; Tim Chole, Rockwell Medical’s Chief Commercial Officer; and Jesse Neri, Rockwell Medical’s Chief Financial Officer.
Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws, including but not limited to the types of statements identified as forward looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC. These statements are subject to risks and uncertainties that could cause actual results to differ.
Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are
Read the full article here
